Susquehanna Fundamental Investments LLC Invests $2.51 Million in Alignment Healthcare, Inc. $ALHC

Susquehanna Fundamental Investments LLC acquired a new stake in Alignment Healthcare, Inc. (NASDAQ:ALHC) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 105,279 shares of the company’s stock, valued at approximately $2,507,000. Susquehanna Fundamental Investments LLC owned about 0.05% of Alignment Healthcare as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also made changes to their positions in the business. Summit Securities Group LLC acquired a new position in Alignment Healthcare in the fourth quarter valued at approximately $26,000. Versant Capital Management Inc raised its holdings in Alignment Healthcare by 463.3% during the second quarter. Versant Capital Management Inc now owns 1,380 shares of the company’s stock worth $33,000 after purchasing an additional 1,135 shares in the last quarter. Parallel Advisors LLC lifted its position in shares of Alignment Healthcare by 87.7% during the 4th quarter. Parallel Advisors LLC now owns 1,654 shares of the company’s stock worth $33,000 after buying an additional 773 shares during the last quarter. Larson Financial Group LLC purchased a new stake in shares of Alignment Healthcare during the 3rd quarter worth approximately $33,000. Finally, Signature Equity Partners LLC acquired a new position in shares of Alignment Healthcare in the 1st quarter valued at $46,000. Institutional investors and hedge funds own 86.19% of the company’s stock.

Analyst Ratings Changes

Several brokerages recently commented on ALHC. Barclays cut their price target on shares of Alignment Healthcare from $19.00 to $16.00 and set an “equal weight” rating on the stock in a research note on Tuesday, May 26th. Weiss Ratings restated a “hold (c-)” rating on shares of Alignment Healthcare in a research note on Tuesday, August 4th. JPMorgan Chase & Co. dropped their price objective on Alignment Healthcare from $26.00 to $22.00 and set an “overweight” rating on the stock in a report on Tuesday, August 4th. TD Cowen reiterated a “buy” rating on shares of Alignment Healthcare in a research report on Monday, August 3rd. Finally, KeyCorp reissued an “overweight” rating on shares of Alignment Healthcare in a report on Wednesday, June 10th. Seven equities research analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $23.60.

Alignment Healthcare Stock Performance

Shares of Alignment Healthcare stock opened at $13.40 on Tuesday. The firm’s fifty day simple moving average is $17.93 and its 200-day simple moving average is $18.47. The stock has a market capitalization of $2.78 billion, a price-to-earnings ratio of 70.53 and a beta of 1.10. Alignment Healthcare, Inc. has a 12 month low of $12.70 and a 12 month high of $25.12. The company has a debt-to-equity ratio of 1.22, a current ratio of 1.70 and a quick ratio of 1.70.

Alignment Healthcare (NASDAQ:ALHC) last issued its quarterly earnings data on Thursday, July 30th. The company reported $0.17 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.13 by $0.04. The company had revenue of $1.34 billion for the quarter, compared to the consensus estimate of $1.31 billion. Alignment Healthcare had a net margin of 0.89% and a return on equity of 20.02%. Alignment Healthcare’s revenue for the quarter was up 31.6% on a year-over-year basis. During the same period last year, the firm posted $0.07 EPS. As a group, equities analysts forecast that Alignment Healthcare, Inc. will post 0.17 earnings per share for the current year.

Insider Buying and Selling at Alignment Healthcare

In other Alignment Healthcare news, President Dawn Christine Maroney sold 30,000 shares of the company’s stock in a transaction that occurred on Monday, June 15th. The stock was sold at an average price of $19.55, for a total transaction of $586,500.00. Following the completion of the sale, the president directly owned 947,313 shares of the company’s stock, valued at $18,519,969.15. This represents a 3.07% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO John E. Kao sold 298,000 shares of the company’s stock in a transaction that occurred on Monday, August 10th. The shares were sold at an average price of $13.88, for a total value of $4,136,240.00. Following the sale, the chief executive officer directly owned 790,766 shares of the company’s stock, valued at approximately $10,975,832.08. This represents a 27.37% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold a total of 1,009,951 shares of company stock worth $18,597,287 over the last three months. 5.20% of the stock is currently owned by corporate insiders.

Alignment Healthcare Profile

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.